107 related articles for article (PubMed ID: 8501786)
1. Enhanced glutathione S-transferase activity and glutathione content in human bladder cancer. Followup study: influence of smoking.
Giralt M; Lafuente A; Pujol F; Mallol J
J Urol; 1993 Jun; 149(6):1452-4. PubMed ID: 8501786
[TBL] [Abstract][Full Text] [Related]
2. Glutathione S-transferase activity and glutathione content in human bladder carcinoma associated with schistosomiasis: comparison with uninvolved surrounding tissues.
Hassan AA; Tagliabue G; Codegoni AM; D'Incalci M; el-Sewedy SM; Airoldi L
Cancer Lett; 1997 Dec; 121(1):19-23. PubMed ID: 9459169
[TBL] [Abstract][Full Text] [Related]
3. Correlative expression of glutathione S-transferase-pi and multidrug resistance associated protein in bladder transitional cell carcinoma.
Yang W; Zeng X; Chen C; Chen Z; Du G
J Tongji Med Univ; 2000; 20(4):311-4. PubMed ID: 12840920
[TBL] [Abstract][Full Text] [Related]
4. Glutathione-S-transferase activity in human superficial transitional cell carcinoma of the bladder. Comparison with healthy controls.
Lafuente A; Giralt M; Cervello I; Pujol F; Mallol J
Cancer; 1990 May; 65(9):2064-8. PubMed ID: 2372771
[TBL] [Abstract][Full Text] [Related]
5. Upregulated glutathione transferase omega-1 correlates with progression of urinary bladder carcinoma.
Djukic T; Simic T; Pljesa-Ercegovac M; Matic M; Suvakov S; Coric V; Dragicevic D; Savic-Radojevic A
Redox Rep; 2017 Nov; 22(6):486-492. PubMed ID: 28288548
[TBL] [Abstract][Full Text] [Related]
6. Glutathione S-transferase activity and subunit composition in transitional cell cancer and mucosa of the human bladder.
Berendsen CL; Peters WH; Scheffer PG; Bouman AA; Boven E; Newling DW
Urology; 1997 Apr; 49(4):644-51. PubMed ID: 9111645
[TBL] [Abstract][Full Text] [Related]
7. Glutathione-S-transferase pi expression in transitional cell carcinoma of the bladder.
Thomas DJ; Birch PJ; Vickers J; Robinson M; Clifford S; Hall A; Neal DE
Br J Urol; 1993 Nov; 72(5 Pt 2):740-3. PubMed ID: 8281406
[TBL] [Abstract][Full Text] [Related]
8. Expression of glutathione S-transferase activity and glutathione content in squamous cell carcinoma of bladder associated with schistosomiasis in a population in Egypt.
Ghazaly GE; Zakahary MM; el-Aziz MA; Mahmoud AA; Carretero P; Lafuente A
Scand J Urol Nephrol; 1997 Feb; 31(1):43-7. PubMed ID: 9060083
[TBL] [Abstract][Full Text] [Related]
9. Glutathione S-transferase and multidrug-resistant phenotype in transitional cell carcinoma of the bladder.
Akdaş A; Türkeri LN; Küllü S; Tarcan T; Sakr W; Grignon DJ
Eur Urol; 1996; 29(4):483-6. PubMed ID: 8791059
[TBL] [Abstract][Full Text] [Related]
10. Translational studies of glutathione in bladder cancer cell lines and human specimens.
Pendyala L; Velagapudi S; Toth K; Zdanowicz J; Glaves D; Slocum H; Perez R; Huben R; Creaven PJ; Raghavan D
Clin Cancer Res; 1997 May; 3(5):793-8. PubMed ID: 9815751
[TBL] [Abstract][Full Text] [Related]
11. Glutathione-linked detoxification pathway in normal and malignant human bladder tissue.
Singh SV; Xu BH; Tkalcevic GT; Gupta V; Roberts B; Ruiz P
Cancer Lett; 1994 Feb; 77(1):15-24. PubMed ID: 8162559
[TBL] [Abstract][Full Text] [Related]
12. Effect of lupeol on antioxidants and xenobiotic enzymes in N-Butyl-N-(4-hydroxybutyl) nitrosamine induced bladder carcinogenesis in experimental rats.
Prabhu B; Sivakumar A; Balakrishnan D; Sundaresan S
J Exp Ther Oncol; 2017 Sep; 11(2):139-416. PubMed ID: 28976137
[TBL] [Abstract][Full Text] [Related]
13. [Bladder wall permeability to to topically administered cisplatin].
Zyrianov BN; Selivanov SP
Urologiia; 2000; (5):28-30. PubMed ID: 11392221
[TBL] [Abstract][Full Text] [Related]
14. Characterization of chemoresistance mechanisms in a series of cisplatin-resistant transitional carcinoma cell lines.
Hour TC; Chen J; Huang CY; Guan JY; Lu SH; Hsieh CY; Pu YS
Anticancer Res; 2000; 20(5A):3221-5. PubMed ID: 11062746
[TBL] [Abstract][Full Text] [Related]
15. Intracellular glutathione content of urothelial cancer in correlation to chemotherapy response.
Yang CR; Ou YC; Kuo JH; Kao YL; Chen CL; Yean SY; Horng YY; Yang CS
Cancer Lett; 1997 Nov; 119(2):157-62. PubMed ID: 9570366
[TBL] [Abstract][Full Text] [Related]
16. Effect of glutathione and its related enzymes on chemosensitivity of renal cell carcinoma and bladder carcinoma cell lines.
Ahn H; Lee E; Kim K; Lee C
J Urol; 1994 Jan; 151(1):263-7. PubMed ID: 8254825
[TBL] [Abstract][Full Text] [Related]
17. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of intracellular platinum is correlated with intrinsic cisplatin resistance in human bladder cancer cell lines.
Koga H; Kotoh S; Nakashima M; Yokomizo A; Tanaka M; Naito S
Int J Oncol; 2000 May; 16(5):1003-7. PubMed ID: 10762637
[TBL] [Abstract][Full Text] [Related]
19. Expression of xenobiotic metabolizing enzymes in tumours of the urinary bladder.
Murray GI; Taylor VE; McKay JA; Weaver RJ; Ewen SW; Melvin WT; Burke MD
Int J Exp Pathol; 1995 Aug; 76(4):271-6. PubMed ID: 7547441
[TBL] [Abstract][Full Text] [Related]
20. Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomas.
Celis JE; Ostergaard M; Basse B; Celis A; Lauridsen JB; Ratz GP; Andersen I; Hein B; Wolf H; Orntoft TF; Rasmussen HH
Cancer Res; 1996 Oct; 56(20):4782-90. PubMed ID: 8840999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
